Altimmune begins MOMENTUM obesity trial for PemvidutideAltimmune has enrolled the first subject in the 48-week Phase 2 MOMENTUM trial evaluating the safety and efficacy of pemvidutide in...
Post-bariatric surgery exercise modulates brain regions associated with regulation of food intake4 days ago
Waist-to-height ratio is a better indicator of outcomes in patients with heart failure than BMI5 days ago